Aclima Therapeutics Derive Private Limited - Company Profile

It is a pharma private limited company based in Greater Noida, Uttar Pradesh, India, established in 2017.
2017 Greater Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Aclima Therapeutics Derive Private Limited

Aclima Therapeutics Derive Private Limited, a active private limited company, was established on 04 October 2017 in Greater Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909UP2017PTC097522. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Ashish Agrawal (Director), Parul Agrawal (Director), Ritie Aggrawal (Director). Past directors included Harish Agarwal Chandra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at L-701, Plumeria Garden Estate, Near Achhar Village Omicron-3, Kasana, Greater Noida, Uttar Pradesh, 201310.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909UP2017PTC097522

  • Registration Number

    097522

  • Incorporation Date

    04 October 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 7.27%
  • Profit Growth **** 6.80%
  • Ebitda **** 10.62%
  • Net Worth 34.90%
  • Total Assets -3.03%
Company report

Aclima Therapeutics Derive Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aclima Therapeutics Derive Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aclima Therapeutics Derive Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashish Agrawal Director 02 Dec 2020 Current
Parul Agrawal Director 04 Oct 2017 Current
Ritie Aggrawal Director 29 May 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Aug 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aclima Therapeutics Derive.

Aclima Therapeutics Derive Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.27% increase. The company also saw a slight improvement in profitability, with a 6.8% increase in profit. The company's net worth Soared by an impressive increase of 34.9%.

Aclima Therapeutics Derive revenue growth over time
Aclima Therapeutics Derive profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.27%
*******
*******
*******
*******
Revenue from Operations
*******
 7.27%
*******
*******
*******
*******
Total Assets
*******
 -3.03%
*******
*******
*******
*******
Profit or Loss
*******
 6.80%
*******
*******
*******
*******
Net Worth
*******
 34.90%
*******
*******
*******
*******
EBITDA
*******
 10.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aclima Therapeutics Derive?

In 2023, Aclima Therapeutics Derive had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aclima Therapeutics Derive?

Unlock and access historical data on people associated with Aclima Therapeutics Derive, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aclima Therapeutics Derive, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aclima Therapeutics Derive's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aclima Therapeutics Derive
Recent Activity within the Organization
  • Annual General Meeting

    Aclima Therapeutics Derive Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Aclima Therapeutics Derive Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    Ashish Agrawal was appointed as a Director was appointed as a Director on 02 Dec 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Ritie Aggrawal was appointed as a Director was appointed as a Director on 29 May 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.

  • Director Appointment

    Parul Agrawal was appointed as a Director was appointed as a Director on 04 Oct 2017 & has been associated with this company since 8 years 5 months . was recorded as a recent event.

  • Company Incorporation

    Aclima Therapeutics Derive Private Limited was registered on 04 Oct 2017 with Roc Kanpur & aged 8 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aclima Therapeutics Derive Private Limited?

The CIN of Aclima Therapeutics Derive Private Limited is U51909UP2017PTC097522.

Where is Aclima Therapeutics Derive Private Limited headquartered?

Aclima Therapeutics Derive Private Limited is headquartered at L-701, Plumeria Garden Estate, Near Achhar Village Omicron-3, Kasana, Greater Noida, Uttar Pradesh, 201310.

When was Aclima Therapeutics Derive Private Limited incorporated?

Aclima Therapeutics Derive Private Limited was incorporated on 04 October 2017.

Who are the current directors of Aclima Therapeutics Derive Private Limited?

The current directors of Aclima Therapeutics Derive Private Limited are

What is the primary industry of Aclima Therapeutics Derive Private Limited?

The primary industry of Aclima Therapeutics Derive Private Limited is Trade.

Is Aclima Therapeutics Derive Private Limited a listed company?

Aclima Therapeutics Derive Private Limited is unlisted.

What is the capital structure of Aclima Therapeutics Derive Private Limited?

The authorized capital of Aclima Therapeutics Derive Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Aclima Therapeutics Derive Private Limited?

The compliance status of Aclima Therapeutics Derive Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available